BBCvsGNOMETF Comparison
Virtus LifeSci Biotech Clinical Trials ETF (BBC) belongs to the Tomorrow's Treatments segment. Global X Genomics & Biotechnology ETF (GNOM) is part of the BioTech & Genomics segment. BBC's top 1 sector exposures are Healthcare. BBC is more expensive with a Total Expense Ratio (TER) of 0.65%, versus 0.5% for GNOM. BBC is up 27.77% year-to-date (YTD) with +$5M in YTD flows. GNOM performs better with 36.95% YTD performance, and +$21M in YTD flows. Run a side-by-side ETF comparison of BBC and GNOM below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
BBC vs GNOM performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | BBC GNOM | -5.78%+4.57% | +17.22%+27.28% | +27.77%+36.95% | +102.82%+69.95% | +137.50%+43.87% | +6.45%-32.85% |
| Flows | BBC GNOM | -+$2M | +$83K+$18M | +$5M+$21M | +$12M+$15M | +$16M-$54M | +$8M-$42M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | BBC GNOM | +33.39%+37.85% | +36.22%+30.56% | +37.22%+30.36% | +39.64%+33.83% |
| Max drawdown | BBC GNOM | -11.65%-8.57% | -14.64%-18.16% | -54.25%-43.10% | -70.43%-71.04% |
| Max drawdown duration | BBC GNOM | 23d32d | 60d145d | 340d674d | 1666d1818d |
BBC | GNOM | |
Last sale 9/14/2026 at 1:30 PM | $49.94 | $63.57 |
| Previous close 09/11/2026 | $49.39 | $62.22 |
| Consolidated volume 09/11/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
BBC | GNOM | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
BBC | GNOM | |
|---|---|---|
| Last price | $49.94 | $63.57 |
| 1D performance | +1.12% | +2.17% |
| AuM | $46.95 M | $93.74 M |
| E/R | 0.65% | 0.5% |
BBC | GNOM | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | VIRTUS Investment Partners | Global X |
| Benchmark | LifeSci Biotechnology Clinical Trials Index | Solactive Genomics Index |
| N° of holdings | 127 | - |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | December 16, 2014 | April 5, 2019 |
| ESG | No | No |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
